Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive
- Status
- RECRUITING
- Phase
- PHASE3
Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cancer of the Lung And SeneScencE - Prospective Cohort 1
- Status
- RECRUITING
- Phase
- NA
Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
- Status
- RECRUITING
- Phase
- NA
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
Firmonertinib Combined With Chemotherapy as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutanted NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Status
- RECRUITING
- Phase
- PHASE3
Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2